• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在年龄相关性黄斑变性患者的眼中,使用维替泊芬通过光动力疗法治疗中心凹旁脉络膜新生血管。

Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.

作者信息

Hariprasad Seenu M, Shah Gaurav K

机构信息

Barnes Retina Institute, 1600 South Brentwood Blvd., 8th Floor, St. Louis, MO 63144, USA.

出版信息

Ophthalmic Surg Lasers Imaging. 2005 May-Jun;36(3):258-60.

PMID:15957487
Abstract

To report the results of treating juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration. Seven patients with predominantly classic juxtafoveal choroidal neovascularization were treated by photodynamic therapy using verteporfin. Three of the 7 patients had a gain in visual acuity and 2 had a stabilization of vision. The remaining 2 patients had a decrease in visual acuity. Subfoveal extension of the choroidal neovascularization was not observed in any patient and all choroidal neovascularization lesions after treatment were found to be nonperfused on fluorescein angiography. The encouraging results based on this small pilot study suggest that photodynamic therapy should be considered for treatment of select juxtafoveal choroidal neovascularization due to age-related macular degeneration.

摘要

报告使用维替泊芬光动力疗法治疗年龄相关性黄斑变性患者的近黄斑中心凹脉络膜新生血管的结果。7例主要为典型性近黄斑中心凹脉络膜新生血管的患者接受了维替泊芬光动力疗法治疗。7例患者中有3例视力提高,2例视力稳定。其余2例患者视力下降。所有患者均未观察到脉络膜新生血管向黄斑中心凹下延伸,治疗后所有脉络膜新生血管病变在荧光素血管造影检查中均显示无灌注。基于这项小型初步研究的令人鼓舞的结果表明,对于因年龄相关性黄斑变性导致的特定近黄斑中心凹脉络膜新生血管,应考虑采用光动力疗法进行治疗。

相似文献

1
Treatment of juxtafoveal choroidal neovascularization with photodynamic therapy using verteporfin in eyes with age-related macular degeneration.在年龄相关性黄斑变性患者的眼中,使用维替泊芬通过光动力疗法治疗中心凹旁脉络膜新生血管。
Ophthalmic Surg Lasers Imaging. 2005 May-Jun;36(3):258-60.
2
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.维替泊芬光动力疗法治疗年龄相关性黄斑变性的中心凹下脉络膜新生血管:两项随机临床试验的一年结果——TAP报告。年龄相关性黄斑变性光动力疗法(TAP)研究组
Arch Ophthalmol. 1999 Oct;117(10):1329-45.
3
Verteporfin therapy of subfoveal choroidal neovascularization in age-related macular degeneration: two-year results of a randomized clinical trial including lesions with occult with no classic choroidal neovascularization--verteporfin in photodynamic therapy report 2.维替泊芬治疗年龄相关性黄斑变性中心凹下脉络膜新生血管:一项随机临床试验的两年结果,该试验纳入隐匿性无典型脉络膜新生血管病变——维替泊芬光动力疗法报告2
Am J Ophthalmol. 2001 May;131(5):541-60. doi: 10.1016/s0002-9394(01)00967-9.
4
Verteporfin therapy of subfoveal minimally classic choroidal neovascularization in age-related macular degeneration: 2-year results of a randomized clinical trial.维替泊芬治疗年龄相关性黄斑变性中黄斑中心凹下轻度典型脉络膜新生血管:一项随机临床试验的2年结果
Arch Ophthalmol. 2005 Apr;123(4):448-57. doi: 10.1001/archopht.123.4.448.
5
Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.维替泊芬疗法联合玻璃体内注射曲安奈德治疗年龄相关性黄斑变性所致的所有类型脉络膜新生血管。
Ophthalmology. 2006 Jan;113(1):14-22. doi: 10.1016/j.ophtha.2005.09.002. Epub 2005 Dec 19.
6
Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.维替泊芬治疗年龄相关性黄斑变性患者的黄斑中心凹下脉络膜新生血管:关于基线病变组成对视力结果影响的补充信息——TAP报告第3号
Arch Ophthalmol. 2002 Nov;120(11):1443-54. doi: 10.1001/archopht.120.11.1443.
7
Photodynamic therapy with verteporfin in patients with age-related macular degeneration and juxtafoveal choroidal neovascularization.
Acta Ophthalmol Scand. 2004 Dec;82(6):651-5. doi: 10.1111/j.1600-0420.2004.00382.x.
8
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials-tap report 2.维替泊芬光动力疗法治疗年龄相关性黄斑变性中心凹下脉络膜新生血管:两项随机临床试验的两年结果——TAP报告2
Arch Ophthalmol. 2001 Feb;119(2):198-207.
9
Combined photodynamic therapy with verteporfin and intravitreal bevacizumab for choroidal neovascularization in age-related macular degeneration.维替泊芬联合玻璃体内注射贝伐单抗光动力疗法治疗年龄相关性黄斑变性脉络膜新生血管
Retina. 2006 Nov-Dec;26(9):988-93. doi: 10.1097/01.iae.0000247164.70376.91.
10
Photodynamic therapy using verteporfin for choroidal neovascularization in angioid streaks.使用维替泊芬治疗血管样条纹脉络膜新生血管的光动力疗法。
Am J Ophthalmol. 2003 Jan;135(1):1-6. doi: 10.1016/s0002-9394(02)01835-4.